Statistics from Altmetric.com
The following information has been produced for Veterinary Record by the Veterinary Medicines Directorate (VMD) to provide an update for veterinary surgeons on recent changes to marketing authorisations for veterinary medicines in the UK.
THE points below highlight changes in marketing authorisations that may have a significant impact on veterinary surgeons' prescribing decisions.
New marketing authorisations
The following new marketing authorisations have been approved during March 2011. There was one new product authorised in this period containing an active substance not previously included in authorised veterinary medicinal products in the UK:
■ Comfortan 10 mg/ml solution for injection for dogs, active substance methadone.
Other new marketing authorisations approved and/or published during March 2011 were:
■ Carprieve 100 mg flavoured tablets for dogs.
■ Carprieve 50 mg flavoured tablets for dogs.
■ Carprieve 20 mg flavoured tablets for dogs.
■ Canileish lyophilsate and solvent for suspension for injection for dogs.
■ Endro Plus flavour tablets for dogs.
■ Endro Plus …